Spinal muscular atrophy: new thoughts on the pathogenesis and classification schema

Area of Science:

• Neurology
• Pediatric Medicine
• Genetics

Background:

• Spinal muscular atrophy (SMA) is the second most frequent neuromuscular disorder in childhood.
• Existing classification systems for SMA may not accurately reflect disease progression or patient outcomes.

Purpose of the Study:

• To conduct the first prospective, collaborative study on spinal muscular atrophy (SMA).
• To re-evaluate the validity of current SMA classification schemas.
• To investigate the mechanisms underlying functional loss in SMA patients.

Main Methods:

• Prospective evaluation of 141 SMA patients over 3 years.
• Grouping patients by age of onset and initial functional status.
• Serial muscle strength assessments using myometry in 96 patients aged 5+ years.
• Functional assessments over an 18-month period for 37 patients.

Main Results:

• The study identified limitations in the current SMA classification system, with patients exhibiting a wider age range than expected.
• 49 patients with early-onset SMA (type I) survived well beyond the typical 2-4 year lifespan.
• Over 18 months, 37 patients maintained muscle strength but experienced functional decline, suggesting a non-cell death mechanism.

Conclusions:

• The current classification of spinal muscular atrophy (SMA) requires revision.
• Functional deterioration in SMA may occur independently of muscle strength loss.
• A novel mechanism, distinct from cell death, might explain functional decline in SMA, preserving muscle strength while hindering motor unit development.